Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Maxim Group to hold a virtual conference » 09:25
05/27/20
05/27
09:25
05/27/20
09:25
APDN

Applied DNA Sciences

$11.78 /

+0.69 (+6.22%)

, BIOC

Biocept

$0.50 /

-0.0041 (-0.82%)

, BNGO

Bionano Genomics

$0.50 /

+0.0322 (+6.87%)

, CAPR

Capricor Therapeutics

$5.26 /

-0.13 (-2.41%)

, CODX

Co-Diagnostics

$18.03 /

-0.57 (-3.06%)

, DXR

Daxor

$14.00 /

-0.03 (-0.21%)

, LCTX

Lineage Cell Therapeutics

$1.04 /

+0.1806 (+21.01%)

, MESO

Mesoblast

$12.95 /

+0.76 (+6.23%)

, PSTI

Pluristem

$7.97 /

-0.39 (-4.67%)

, VNRX

VolitionRx

$3.11 /

+0.12 (+4.01%)

Maxim Group Virtual…

Maxim Group Virtual COVID-19 Conference will be held on May 27.

ShowHide Related Items >><<
VNRX VolitionRx
$3.11 /

+0.12 (+4.01%)

PSTI Pluristem
$7.97 /

-0.39 (-4.67%)

MESO Mesoblast
$12.95 /

+0.76 (+6.23%)

LCTX Lineage Cell Therapeutics
$1.04 /

+0.1806 (+21.01%)

DXR Daxor
$14.00 /

-0.03 (-0.21%)

CODX Co-Diagnostics
$18.03 /

-0.57 (-3.06%)

CAPR Capricor Therapeutics
$5.26 /

-0.13 (-2.41%)

BNGO Bionano Genomics
$0.50 /

+0.0322 (+6.87%)

BIOC Biocept
$0.50 /

-0.0041 (-0.82%)

APDN Applied DNA Sciences
$11.78 /

+0.69 (+6.22%)

APDN Applied DNA Sciences
$11.78 /

+0.69 (+6.22%)

05/05/20 Maxim
Applied DNA Sciences price target raised to $18 from $8 at Maxim
11/22/19
Fly Intel: Top five analyst upgrades
11/22/19 Maxim
Applied DNA Sciences upgraded to Buy from Hold at Maxim
BIOC Biocept
$0.50 /

-0.0041 (-0.82%)

05/14/20 Brookline
Biocept initiated with a Buy at Brookline
BNGO Bionano Genomics
$0.50 /

+0.0322 (+6.87%)

04/08/20 Oppenheimer
Oppenheimer bullish on Bionano Genomics, initiates with an Outperform
04/08/20 Oppenheimer
Bionano Genomics initiated with an Outperform at Oppenheimer
CAPR Capricor Therapeutics
$5.26 /

-0.13 (-2.41%)

02/03/20 Maxim
Capricor Therapeutics upgraded to Buy from Hold at Maxim
07/15/19 H.C. Wainwright
Capricor price target raised to $12.40 from $3.50 at H.C. Wainwright
CODX Co-Diagnostics
$18.03 /

-0.57 (-3.06%)

05/20/20 Maxim
Co-Diagnostics upgraded to Buy from Hold at Maxim
05/20/20 Maxim
Co-Diagnostics upgraded to Buy from Hold at Maxim
05/18/20 H.C. Wainwright
Co-Diagnostics price target raised to $35 from $20 at H.C. Wainwright
03/09/20 H.C. Wainwright
Co-Diagnostics price target raised to $20 from $4 at H.C. Wainwright
DXR Daxor
$14.00 /

-0.03 (-0.21%)

09/30/19 Roth Capital
Daxor initiated with a Neutral at Roth Capital
07/29/19
Daxor initiated with a Buy at Maxim
07/29/19 Maxim
Daxor initiated with a Buy at Maxim
LCTX Lineage Cell Therapeutics
$1.04 /

+0.1806 (+21.01%)

05/06/20 H.C. Wainwright
Lineage update shows OpRegen 'nicely on track,' says H.C. Wainwright
MESO Mesoblast
$12.95 /

+0.76 (+6.23%)

04/09/20 H.C. Wainwright
H.C. Wainwright 'encouraged' by Mesoblast's plan to study Ryoncil in ARDS
10/22/19 Cantor Fitzgerald
Mesoblast assumed with an Overweight at Cantor Fitzgerald
09/10/19 Cantor Fitzgerald
Mesoblast partnership deal with Grunenthal a positive, says Cantor Fitzgerald
PSTI Pluristem
$7.97 /

-0.39 (-4.67%)

04/24/20 H.C. Wainwright
Pluristem removed overhang with loan agreement, says H.C. Wainwright
04/13/20 Maxim
Pluristem price target raised to $12 from $8 at Maxim
04/07/20 H.C. Wainwright
Early COVID-19 results 'a game changer' for Pluristem, says H.C. Wainwright
02/10/20 Dawson James
Pluristem could have 'blockbuster' therapy for CLI, says Dawson James
VNRX VolitionRx
$3.11 /

+0.12 (+4.01%)

05/06/20 Aegis
VolitionRx initiated with a Buy at Aegis
LCTX Lineage Cell Therapeutics
$1.04 /

+0.1806 (+21.01%)

CODX Co-Diagnostics
$18.03 /

-0.57 (-3.06%)

CAPR Capricor Therapeutics
$5.26 /

-0.13 (-2.41%)

BNGO Bionano Genomics
$0.50 /

+0.0322 (+6.87%)

CODX Co-Diagnostics
$18.03 /

-0.57 (-3.06%)

VNRX VolitionRx
$3.11 /

+0.12 (+4.01%)

MESO Mesoblast
$12.95 /

+0.76 (+6.23%)

CODX Co-Diagnostics
$18.03 /

-0.57 (-3.06%)

APDN Applied DNA Sciences
$11.78 /

+0.69 (+6.22%)

VNRX VolitionRx
$3.11 /

+0.12 (+4.01%)

PSTI Pluristem
$7.97 /

-0.39 (-4.67%)

MESO Mesoblast
$12.95 /

+0.76 (+6.23%)

CODX Co-Diagnostics
$18.03 /

-0.57 (-3.06%)

CAPR Capricor Therapeutics
$5.26 /

-0.13 (-2.41%)

Hot Stocks
Co-Diagnostics announces publication of Logix Smart COVID-19 Test Kit paper » 06:39
05/26/20
05/26
06:39
05/26/20
06:39
CODX

Co-Diagnostics

$18.60 /

+0.6 (+3.33%)

Co-Diagnostics announced…

Co-Diagnostics announced the publication of a paper showing its Logix Smart COVID-19 Test Kit was used to demonstrate that the SARS-CoV-2 virus can be detected in cancer tissue of coronavirus patients, even before symptoms occur. The peer-reviewed paper, published in the Journal of Clinical Pathology, described a study performed at the European Institute of Oncology. Researchers used the company's test to determine whether SARS-CoV-2 was present in the removed tumor of a man who later become symptomatic and was diagnosed with COVID-19. The tumor, removed from the patient's tongue, was embedded in formalin-fixed paraffin and later tested with the company's COVID-19 test kit, along with non-cancer tissue removed from the patient's salivary glands and lymph nodes. Ten FFPE samples and six bronchoalveolar samples from other patients without COVID-19 were also tested. Co-Diagnostics' test was used by researchers to identify the COVID-19-causing virus in the coronavirus patient's FFPE and salivary gland samples and returned negative results on the lymph node samples, consistent with where the virus is known to be found. All other samples from all non-COVID-19 patients were likewise negative. The researchers also describe a recent similar study in China where that study's authors were unable to detect the presence of the virus in lung specimen FFPE samples of COVID-19 positive patients, due to the lack of a sufficiently robust test.

ShowHide Related Items >><<
CODX Co-Diagnostics
$18.60 /

+0.6 (+3.33%)

CODX Co-Diagnostics
$18.60 /

+0.6 (+3.33%)

05/20/20 Maxim
Co-Diagnostics upgraded to Buy from Hold at Maxim
05/20/20 Maxim
Co-Diagnostics upgraded to Buy from Hold at Maxim
05/18/20 H.C. Wainwright
Co-Diagnostics price target raised to $35 from $20 at H.C. Wainwright
03/09/20 H.C. Wainwright
Co-Diagnostics price target raised to $20 from $4 at H.C. Wainwright
CODX Co-Diagnostics
$18.60 /

+0.6 (+3.33%)

CODX Co-Diagnostics
$18.60 /

+0.6 (+3.33%)

CODX Co-Diagnostics
$18.60 /

+0.6 (+3.33%)

CODX Co-Diagnostics
$18.60 /

+0.6 (+3.33%)

Options
Largest borrow rate increases among liquid names » 08:45
05/21/20
05/21
08:45
05/21/20
08:45
APHA

Aphria

$3.62 /

+0.09 (+2.55%)

, CVM

CEL-SCI

$14.49 /

-0.92 (-5.97%)

, JMIA

Jumia Technologies

$4.60 /

+0.29 (+6.73%)

, GSX

GSX Techedu

$30.62 /

-3.24 (-9.57%)

, APPN

Appian

$57.98 /

+1.17 (+2.06%)

, CLVS

Clovis

$7.48 /

-0.035 (-0.47%)

, CODX

Co-Diagnostics

$18.54 /

-0.28 (-1.49%)

, DNR

Denbury Resources

$0.26 /

+ (+0.00%)

, FXI

iShares China Large-Cap ETF

$39.59 /

+0.51 (+1.31%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Aphria (APHA) 79.02% +3.70, Cel Sci (CVM) 18.88% +1.06, Jumia Technologies (JMIA) 5.64% +0.79, Direxion Daily S&P Bull (SPXL) 2.38% +0.67, GSX Techedu (GSX) 2.23% +0.39, Appian Corp (APPN) 11.39% +0.30, Clovis (CLVS) 36.85% +0.29, Co-Diagnostics (CODX) 145.97% +0.22, Denbury Resources (DNR) 2.12% +0.16, and iShares China Large Cap ETF (FXI) 1.05% +0.16.

ShowHide Related Items >><<
JMIA Jumia Technologies
$4.60 /

+0.29 (+6.73%)

GSX GSX Techedu
$30.62 /

-3.24 (-9.57%)

DNR Denbury Resources
$0.26 /

+ (+0.00%)

CVM CEL-SCI
$14.49 /

-0.92 (-5.97%)

CODX Co-Diagnostics
$18.54 /

-0.28 (-1.49%)

CLVS Clovis
$7.48 /

-0.035 (-0.47%)

APPN Appian
$57.98 /

+1.17 (+2.06%)

APHA Aphria
$3.62 /

+0.09 (+2.55%)

APHA Aphria
$3.62 /

+0.09 (+2.55%)

05/13/20 Cantor Fitzgerald
Aphria price target lowered to C$9.55 from C$9.85 at Cantor Fitzgerald
04/16/20 CIBC
Aphria price target lowered to C$6 from C$7 at CIBC
04/16/20 Canaccord
Aphria strong adult-use growth well-above expectations, says Canaccord
04/15/20 Alliance Global Partners
Aphria price target lowered to C$9 from C$11 at Alliance Global Partners
CVM CEL-SCI
$14.49 /

-0.92 (-5.97%)

05/14/20 H.C. Wainwright
CEL-SCI price target raised to $23 from $18 at H.C. Wainwright
01/13/20 H.C. Wainwright
CEL-SCI initiated with a Buy at H.C. Wainwright
JMIA Jumia Technologies
$4.60 /

+0.29 (+6.73%)

05/14/20 Stifel
Jumia Technologies downgraded to Hold from Buy at Stifel
03/25/20 Berenberg
Jumia Technologies downgraded to Hold from Buy at Berenberg
02/26/20 RBC Capital
Jumia Technologies price target lowered to $13 from $22 at RBC Capital
02/25/20 Stifel
Jumia Technologies price target lowered to $8 from $10 at Stifel
GSX GSX Techedu
$30.62 /

-3.24 (-9.57%)

05/11/20 Barclays
GSX Techedu offered comprehensive rebuttal to short sellers, says Barclays
05/11/20 Nomura Instinet
GSX Techedu price target raised to $40 from $35 at Nomura Instinet
05/07/20 CLSA
GSX Techedu downgraded to Sell from Outperform at CLSA
05/07/20 Citi
GSX Techedu share buyback to offer support, says Citi
APPN Appian
$57.98 /

+1.17 (+2.06%)

04/14/20 Morgan Stanley
Appian downgraded to Underweight on near-term challenges at Morgan Stanley
04/14/20 Morgan Stanley
Appian downgraded to Underweight from Equal Weight at Morgan Stanley
02/19/20 Needham
Appian downgraded to Hold from Buy at Needham
02/19/20 Needham
Appian downgraded to Hold from Buy at Needham
CLVS Clovis
$7.48 /

-0.035 (-0.47%)

05/18/20 H.C. Wainwright
Clovis price target raised to $33 from $29 at H.C. Wainwright
05/06/20 H.C. Wainwright
Clovis price target raised to $29 from $27 at H.C. Wainwright
05/06/20 Piper Sandler
Clovis price target raised to $6 from $5.25 at Piper Sandler
04/27/20 SVB Leerink
Clovis downgraded to Underperform at SVB Leerink as prostate opportunity fades
CODX Co-Diagnostics
$18.54 /

-0.28 (-1.49%)

05/20/20 Maxim
Co-Diagnostics upgraded to Buy from Hold at Maxim
05/20/20 Maxim
Co-Diagnostics upgraded to Buy from Hold at Maxim
05/18/20 H.C. Wainwright
Co-Diagnostics price target raised to $35 from $20 at H.C. Wainwright
03/09/20 H.C. Wainwright
Co-Diagnostics price target raised to $20 from $4 at H.C. Wainwright
DNR Denbury Resources
$0.26 /

+ (+0.00%)

03/31/20 Stifel
Denbury Resources downgraded to Sell from Hold at Stifel
03/20/20 Stephens
Stephens upgrades Hess, downgrades 11 others in E&P following oil's melt down
03/20/20 Stephens
Denbury Resources downgraded to Underweight from Equal Weight at Stephens
06/06/19 Imperial Capital
Denbury Resources price target lowered to $2 from $3 at Imperial Capital
FXI iShares China Large-Cap ETF
$39.59 /

+0.51 (+1.31%)

GSX GSX Techedu
$30.62 /

-3.24 (-9.57%)

DNR Denbury Resources
$0.26 /

+ (+0.00%)

CODX Co-Diagnostics
$18.54 /

-0.28 (-1.49%)

CLVS Clovis
$7.48 /

-0.035 (-0.47%)

APPN Appian
$57.98 /

+1.17 (+2.06%)

APHA Aphria
$3.62 /

+0.09 (+2.55%)

  • 19
    May
GSX GSX Techedu
$30.62 /

-3.24 (-9.57%)

DNR Denbury Resources
$0.26 /

+ (+0.00%)

CODX Co-Diagnostics
$18.54 /

-0.28 (-1.49%)

CLVS Clovis
$7.48 /

-0.035 (-0.47%)

APHA Aphria
$3.62 /

+0.09 (+2.55%)

JMIA Jumia Technologies
$4.60 /

+0.29 (+6.73%)

GSX GSX Techedu
$30.62 /

-3.24 (-9.57%)

CVM CEL-SCI
$14.49 /

-0.92 (-5.97%)

CODX Co-Diagnostics
$18.54 /

-0.28 (-1.49%)

CLVS Clovis
$7.48 /

-0.035 (-0.47%)

APPN Appian
$57.98 /

+1.17 (+2.06%)

APHA Aphria
$3.62 /

+0.09 (+2.55%)

CLVS Clovis
$7.48 /

-0.035 (-0.47%)

JMIA Jumia Technologies
$4.60 /

+0.29 (+6.73%)

GSX GSX Techedu
$30.62 /

-3.24 (-9.57%)

FXI iShares China Large-Cap ETF
$39.59 /

+0.51 (+1.31%)

DNR Denbury Resources
$0.26 /

+ (+0.00%)

CVM CEL-SCI
$14.49 /

-0.92 (-5.97%)

CODX Co-Diagnostics
$18.54 /

-0.28 (-1.49%)

CLVS Clovis
$7.48 /

-0.035 (-0.47%)

APPN Appian
$57.98 /

+1.17 (+2.06%)

APHA Aphria
$3.62 /

+0.09 (+2.55%)

Upgrade
Co-Diagnostics upgraded to Buy from Hold at Maxim » 07:57
05/20/20
05/20
07:57
05/20/20
07:57
CODX

Co-Diagnostics

$18.83 /

+1.43 (+8.22%)

Maxim analyst Jason…

Maxim analyst Jason McCarthy upgraded Co-Diagnostics to Buy from Hold with a $30 price target. The analyst cites the company's $16M quarter-to-date revenue contribution from its COVID-19 testing in Q2, stating that its test is rapidly emerging as a go-to PCR kit in the U.S. and overseas. McCarth adds that Co-Diagnostics' Logix Smart test "meets expectations on performance, pricing and throughput", anticipating significant revenue growth for the company's COVID-19 testing as well as its already marketed infectious disease tests.

ShowHide Related Items >><<
CODX Co-Diagnostics
$18.83 /

+1.43 (+8.22%)

CODX Co-Diagnostics
$18.83 /

+1.43 (+8.22%)

05/20/20 Maxim
Co-Diagnostics upgraded to Buy from Hold at Maxim
05/18/20 H.C. Wainwright
Co-Diagnostics price target raised to $35 from $20 at H.C. Wainwright
03/09/20 H.C. Wainwright
Co-Diagnostics price target raised to $20 from $4 at H.C. Wainwright
03/03/20
Fly Intel: Top five analyst downgrades
CODX Co-Diagnostics
$18.83 /

+1.43 (+8.22%)

CODX Co-Diagnostics
$18.83 /

+1.43 (+8.22%)

CODX Co-Diagnostics
$18.83 /

+1.43 (+8.22%)

CODX Co-Diagnostics
$18.83 /

+1.43 (+8.22%)

Upgrade
Co-Diagnostics upgraded to Buy from Hold at Maxim » 07:39
05/20/20
05/20
07:39
05/20/20
07:39
CODX

Co-Diagnostics

$18.83 /

+1.43 (+8.22%)

Maxim analyst Jason…

Maxim analyst Jason McCarthy upgraded Co-Diagnostics to Buy from Hold.

ShowHide Related Items >><<
CODX Co-Diagnostics
$18.83 /

+1.43 (+8.22%)

CODX Co-Diagnostics
$18.83 /

+1.43 (+8.22%)

05/18/20 H.C. Wainwright
Co-Diagnostics price target raised to $35 from $20 at H.C. Wainwright
03/09/20 H.C. Wainwright
Co-Diagnostics price target raised to $20 from $4 at H.C. Wainwright
03/03/20
Fly Intel: Top five analyst downgrades
03/03/20 Maxim
Co-Diagnostics downgraded to Hold from Buy at Maxim
CODX Co-Diagnostics
$18.83 /

+1.43 (+8.22%)

CODX Co-Diagnostics
$18.83 /

+1.43 (+8.22%)

CODX Co-Diagnostics
$18.83 /

+1.43 (+8.22%)

CODX Co-Diagnostics
$18.83 /

+1.43 (+8.22%)

Recommendations
Co-Diagnostics price target raised to $35 from $20 at H.C. Wainwright » 07:19
05/18/20
05/18
07:19
05/18/20
07:19
CODX

Co-Diagnostics

$17.01 /

-5.18 (-23.34%)

H.C. Wainwright analyst…

H.C. Wainwright analyst Yi Chen raised the firm's price target on Co-Diagnostics to $35 from $20 and reiterates a Buy rating on the shares following the company's Q1 results. Management noted that Q1 revenue was driven by sales of the Logix Smart COVID-19 test, which has been sold through a network of distributors in nearly 50 countries as well as 15 U.S. states, Chen tells investors in a research note. In order to meet market demand, Co-Diagnostics has increased its capacity of production at its Salt Lake City facility, its CoSara joint venture facility in India, and through Promega in the U.S., adds the analyst. Given the higher than expected market demand for COVID-19 testing, Chen increased the firm's Q2 revenue projection to $27M and 2020 revenue projection to $83.5M from $37.1M.

ShowHide Related Items >><<
CODX Co-Diagnostics
$17.01 /

-5.18 (-23.34%)

CODX Co-Diagnostics
$17.01 /

-5.18 (-23.34%)

03/09/20 H.C. Wainwright
Co-Diagnostics price target raised to $20 from $4 at H.C. Wainwright
03/03/20
Fly Intel: Top five analyst downgrades
03/03/20 Maxim
Co-Diagnostics downgraded to Hold from Buy at Maxim
03/03/20 Maxim
Co-Diagnostics downgraded to Hold from Buy at Maxim
CODX Co-Diagnostics
$17.01 /

-5.18 (-23.34%)

CODX Co-Diagnostics
$17.01 /

-5.18 (-23.34%)

CODX Co-Diagnostics
$17.01 /

-5.18 (-23.34%)

CODX Co-Diagnostics
$17.01 /

-5.18 (-23.34%)

On The Fly
Fly Intel: Wall Street's top stories for Friday » 16:43
05/15/20
05/15
16:43
05/15/20
16:43
AMAT

Applied Materials

$52.02 /

-2.49 (-4.57%)

, KLAC

KLA Corp.

$167.25 /

-8.71 (-4.95%)

, LRCX

Lam Research

$251.84 /

-17.35 (-6.45%)

, TSM

TSMC

$49.85 /

-2.27 (-4.36%)

, SRNE

Sorrento Therapeutics

$6.71 /

+4.085 (+155.62%)

, ABT

Abbott

$89.87 /

-1.845 (-2.01%)

, FB

Facebook

$211.02 /

+4.29 (+2.08%)

, DKNG

DraftKings

$29.20 /

+3.915 (+15.48%)

, SRPT

Sarepta

$141.19 /

+14.04 (+11.04%)

, PFE

Pfizer

$37.77 /

-0.15 (-0.40%)

, MCK

McKesson

$136.46 /

+7.3 (+5.65%)

, ACB

Aurora Cannabis

$10.86 /

+4.25 (+64.30%)

, DDS

Dillard's

$25.83 /

+2.89 (+12.60%)

, GOOS

Canada Goose

$19.21 /

-1.47 (-7.11%)

, CODX

Co-Diagnostics

$17.01 /

-5.18 (-23.34%)

Stocks held up relatively…

Open Full Text

ShowHide Related Items >><<
TSM TSMC
$49.85 /

-2.27 (-4.36%)

SRPT Sarepta
$141.19 /

+14.04 (+11.04%)

SRNE Sorrento Therapeutics
$6.71 /

+4.085 (+155.62%)

PFE Pfizer
$37.77 /

-0.15 (-0.40%)

MCK McKesson
$136.46 /

+7.3 (+5.65%)

LRCX Lam Research
$251.84 /

-17.35 (-6.45%)

KLAC KLA Corp.
$167.25 /

-8.71 (-4.95%)

GOOS Canada Goose
$19.21 /

-1.47 (-7.11%)

FB Facebook
$211.02 /

+4.29 (+2.08%)

DKNG DraftKings
$29.20 /

+3.915 (+15.48%)

DDS Dillard's
$25.83 /

+2.89 (+12.60%)

CODX Co-Diagnostics
$17.01 /

-5.18 (-23.34%)

AMAT Applied Materials
$52.02 /

-2.49 (-4.57%)

ACB Aurora Cannabis
$10.86 /

+4.25 (+64.30%)

ABT Abbott
$89.87 /

-1.845 (-2.01%)

AMAT Applied Materials
$52.02 /

-2.49 (-4.57%)

05/15/20
Fly Intel: Top five analyst upgrades
05/15/20 DA Davidson
Applied Materials price target raised to $55 from $50 at DA Davidson
05/15/20 Needham
Applied Materials price target lowered to $70 from $73 at Needham
05/15/20 B. Riley FBR
B. Riley FBR upgrades Applied Materials to Buy on growth visibility
KLAC KLA Corp.
$167.25 /

-8.71 (-4.95%)

05/06/20 Wells Fargo
KLA Corp. price target raised to $160 from $140 at Wells Fargo
05/06/20 KeyBanc
KLA Corp. price target lowered to $182 from $204 at KeyBanc
05/06/20 Citi
KLA Corp. price target raised to $178 from $158 at Citi
04/08/20 Exane BNP Paribas
KLA Corp. reinstated with an Outperform at Exane BNP Paribas
LRCX Lam Research
$251.84 /

-17.35 (-6.45%)

04/23/20 DA Davidson
Lam Research price target raised to $270 from $250 at DA Davidson
04/23/20 Wells Fargo
Lam Research price target raised to $270 from $210 at Wells Fargo
04/23/20 Susquehanna
Lam Research price target lowered to $330 from $368 at Susquehanna
04/23/20 Needham
Lam Research price target lowered to $325 from $340 at Needham
TSM TSMC
$49.85 /

-2.27 (-4.36%)

04/28/20
Fly Intel: Top five analyst initiations
04/28/20 Wedbush
Wedbush bullish on TSMC, initiates with an Outperform
04/27/20 Wedbush
TSMC initiated with an Outperform at Wedbush
04/17/20 Susquehanna
TSMC downgraded to Negative from Positive at Susquehanna
SRNE Sorrento Therapeutics
$6.71 /

+4.085 (+155.62%)

10/07/19 JMP Securities
Sorrento Therapeutics initiated with an Outperform at JMP Securities
07/23/19 H.C. Wainwright
Sorrento Therapeutics price target lowered to $30 from $40 at H.C. Wainwright
ABT Abbott
$89.87 /

-1.845 (-2.01%)

04/20/20 Barclays
Abbott price target raised to $100 from $92 at Barclays
04/20/20 Barclays
Abbott price target raised to $100 from $92 at Barclays
04/17/20 Raymond James
Abbott price target raised to $102 from $92 at Raymond James
04/17/20 Credit Suisse
Abbott price target raised to $106 from $95 at Credit Suisse
FB Facebook
$211.02 /

+4.29 (+2.08%)

05/15/20 Loop Capital
Facebook price target raised to $265 from $215 at Loop Capital
05/04/20 Argus
Facebook price target raised to $240 from $220 at Argus
05/01/20 BMO Capital
Facebook price target raised to $220 from $190 at BMO Capital
04/30/20
Fly Intel: Top five analyst upgrades
DKNG DraftKings
$29.20 /

+3.915 (+15.48%)

05/15/20 Canaccord
DraftKings price target raised to $35 from $25 at Canaccord
05/14/20
Fly Intel: Top five analyst initiations
05/14/20 Craig-Hallum
DraftKings price target raised to $30 from $25 at Craig-Hallum
05/14/20 Susquehanna
DraftKings initiated with a Positive at Susquehanna
SRPT Sarepta
$141.19 /

+14.04 (+11.04%)

05/15/20 Goldman Sachs
After Pfizer data, Goldman says Sarepta remains 'leader' in DMD gene therapy
05/15/20 William Blair
Sarepta remains the leader after Pfizer DMD data, says William Blair
05/15/20 William Blair
Sarepta remains the leader after Pfizer DMD data, says William Blair
05/15/20 JPMorgan
JPMorgan still sees Sarepta in pole position in DMD space
PFE Pfizer
$37.77 /

-0.15 (-0.40%)

05/15/20 William Blair
Sarepta maintains leadership position after Pfizer data, says William Blair
05/15/20 H.C. Wainwright
H.C. Wainwright calls Sarepta 'best of breed' after Pfizer DMD data
MCK McKesson
$136.46 /

+7.3 (+5.65%)

05/15/20 Gordon Haskett
Gordon Haskett points to possible signs of activism at Dropbox, McKesson
05/15/20 UBS
McKesson, Cardinal Health upgraded to Buy from Neutral at UBS
05/15/20 UBS
McKesson upgraded to Buy from Neutral at UBS
04/22/20 Credit Suisse
McKesson initiated with a Neutral at Credit Suisse
ACB Aurora Cannabis
$10.86 /

+4.25 (+64.30%)

05/15/20 MKM Partners
Aurora Cannabis price target raised to C$12 from C$1 at MKM Partners
05/15/20 Piper Sandler
Aurora Cannabis upgraded to Neutral from Underweight at Piper Sandler
05/13/20 Cantor Fitzgerald
Aurora Cannabis price target raised to C$22 from C$2.75 at Cantor Fitzgerald
04/08/20 Raymond James
Ontario AG order positive for Canadian cannabis stocks, says Raymond James
DDS Dillard's
$25.83 /

+2.89 (+12.60%)

05/15/20 JPMorgan
Dillard's price target lowered to $23 from $32 at JPMorgan
05/07/20 Deutsche Bank
Dillard's price target lowered to $18 from $36 at Deutsche Bank
04/30/20 Wedbush
Dillard's price target lowered to $25 from $63 at Wedbush
01/24/20 Odeon Capital
Dillard's initiated with a Sell at Odeon Capital
GOOS Canada Goose
$19.21 /

-1.47 (-7.11%)

05/15/20 BofA
Canada Goose downgraded to Underperform from Neutral at BofA
05/15/20 BofA
Canada Goose downgraded to Underperform from Neutral at BofA
04/28/20 BTIG
Canada Goose initiated with a Buy at BTIG
04/15/20 CIBC
Canada Goose price target lowered to C$35 from C$57 at CIBC
CODX Co-Diagnostics
$17.01 /

-5.18 (-23.34%)

03/09/20 H.C. Wainwright
Co-Diagnostics price target raised to $20 from $4 at H.C. Wainwright
03/03/20
Fly Intel: Top five analyst downgrades
03/03/20 Maxim
Co-Diagnostics downgraded to Hold from Buy at Maxim
03/03/20 Maxim
Co-Diagnostics downgraded to Hold from Buy at Maxim
TSM TSMC
$49.85 /

-2.27 (-4.36%)

SRPT Sarepta
$141.19 /

+14.04 (+11.04%)

PFE Pfizer
$37.77 /

-0.15 (-0.40%)

MCK McKesson
$136.46 /

+7.3 (+5.65%)

LRCX Lam Research
$251.84 /

-17.35 (-6.45%)

KLAC KLA Corp.
$167.25 /

-8.71 (-4.95%)

GOOS Canada Goose
$19.21 /

-1.47 (-7.11%)

FB Facebook
$211.02 /

+4.29 (+2.08%)

DKNG DraftKings
$29.20 /

+3.915 (+15.48%)

DDS Dillard's
$25.83 /

+2.89 (+12.60%)

CODX Co-Diagnostics
$17.01 /

-5.18 (-23.34%)

AMAT Applied Materials
$52.02 /

-2.49 (-4.57%)

ACB Aurora Cannabis
$10.86 /

+4.25 (+64.30%)

ABT Abbott
$89.87 /

-1.845 (-2.01%)

TSM TSMC
$49.85 /

-2.27 (-4.36%)

SRPT Sarepta
$141.19 /

+14.04 (+11.04%)

SRNE Sorrento Therapeutics
$6.71 /

+4.085 (+155.62%)

PFE Pfizer
$37.77 /

-0.15 (-0.40%)

MCK McKesson
$136.46 /

+7.3 (+5.65%)

LRCX Lam Research
$251.84 /

-17.35 (-6.45%)

GOOS Canada Goose
$19.21 /

-1.47 (-7.11%)

FB Facebook
$211.02 /

+4.29 (+2.08%)

CODX Co-Diagnostics
$17.01 /

-5.18 (-23.34%)

AMAT Applied Materials
$52.02 /

-2.49 (-4.57%)

ACB Aurora Cannabis
$10.86 /

+4.25 (+64.30%)

ABT Abbott
$89.87 /

-1.845 (-2.01%)

TSM TSMC
$49.85 /

-2.27 (-4.36%)

SRPT Sarepta
$141.19 /

+14.04 (+11.04%)

SRNE Sorrento Therapeutics
$6.71 /

+4.085 (+155.62%)

PFE Pfizer
$37.77 /

-0.15 (-0.40%)

MCK McKesson
$136.46 /

+7.3 (+5.65%)

LRCX Lam Research
$251.84 /

-17.35 (-6.45%)

KLAC KLA Corp.
$167.25 /

-8.71 (-4.95%)

GOOS Canada Goose
$19.21 /

-1.47 (-7.11%)

FB Facebook
$211.02 /

+4.29 (+2.08%)

DKNG DraftKings
$29.20 /

+3.915 (+15.48%)

CODX Co-Diagnostics
$17.01 /

-5.18 (-23.34%)

AMAT Applied Materials
$52.02 /

-2.49 (-4.57%)

ACB Aurora Cannabis
$10.86 /

+4.25 (+64.30%)

ABT Abbott
$89.87 /

-1.845 (-2.01%)

TSM TSMC
$49.85 /

-2.27 (-4.36%)

SRPT Sarepta
$141.19 /

+14.04 (+11.04%)

SRNE Sorrento Therapeutics
$6.71 /

+4.085 (+155.62%)

PFE Pfizer
$37.77 /

-0.15 (-0.40%)

MCK McKesson
$136.46 /

+7.3 (+5.65%)

LRCX Lam Research
$251.84 /

-17.35 (-6.45%)

GOOS Canada Goose
$19.21 /

-1.47 (-7.11%)

FB Facebook
$211.02 /

+4.29 (+2.08%)

DKNG DraftKings
$29.20 /

+3.915 (+15.48%)

CODX Co-Diagnostics
$17.01 /

-5.18 (-23.34%)

AMAT Applied Materials
$52.02 /

-2.49 (-4.57%)

ACB Aurora Cannabis
$10.86 /

+4.25 (+64.30%)

ABT Abbott
$89.87 /

-1.845 (-2.01%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:31
05/15/20
05/15
12:31
05/15/20
12:31
AMAT

Applied Materials

$51.41 /

-3.1 (-5.69%)

, LRCX

Lam Research

$252.00 /

-17.19 (-6.39%)

, TSM

TSMC

$49.52 /

-2.6 (-4.99%)

, KLAC

KLA Corp.

$168.66 /

-7.3 (-4.15%)

, FB

Facebook

$207.15 /

+0.42 (+0.20%)

, ABT

Abbott

$89.66 /

-2.055 (-2.24%)

, SRNE

Sorrento Therapeutics

$7.72 /

+5.095 (+194.10%)

, ODP

Office Depot

$2.18 /

+0.175 (+8.73%)

, ACB

Aurora Cannabis

$11.25 /

+4.64 (+70.20%)

, DDS

Dillard's

$24.69 /

+1.75 (+7.63%)

, GOOS

Canada Goose

$19.19 /

-1.49 (-7.21%)

, CODX

Co-Diagnostics

$17.49 /

-4.7 (-21.18%)

, QCOM

Qualcomm

$75.37 /

-4.49 (-5.62%)

, AAPL

Apple

$304.43 /

-5.13 (-1.66%)

, BA

Boeing

$119.50 /

-2.95 (-2.41%)

, CSCO

Cisco

$44.01 /

+0.14 (+0.32%)

Stocks are closing out a…

Open Full Text

ShowHide Related Items >><<
TSM TSMC
$49.52 /

-2.6 (-4.99%)

SRNE Sorrento Therapeutics
$7.72 /

+5.095 (+194.10%)

QCOM Qualcomm
$75.37 /

-4.49 (-5.62%)

ODP Office Depot
$2.18 /

+0.175 (+8.73%)

LRCX Lam Research
$252.00 /

-17.19 (-6.39%)

KLAC KLA Corp.
$168.66 /

-7.3 (-4.15%)

GOOS Canada Goose
$19.19 /

-1.49 (-7.21%)

FB Facebook
$207.15 /

+0.42 (+0.20%)

DDS Dillard's
$24.69 /

+1.75 (+7.63%)

CSCO Cisco
$44.01 /

+0.14 (+0.32%)

CODX Co-Diagnostics
$17.49 /

-4.7 (-21.18%)

BA Boeing
$119.50 /

-2.95 (-2.41%)

AMAT Applied Materials
$51.41 /

-3.1 (-5.69%)

ACB Aurora Cannabis
$11.25 /

+4.64 (+70.20%)

ABT Abbott
$89.66 /

-2.055 (-2.24%)

AAPL Apple
$304.43 /

-5.13 (-1.66%)

AMAT Applied Materials
$51.41 /

-3.1 (-5.69%)

05/15/20
Fly Intel: Top five analyst upgrades
05/15/20 DA Davidson
Applied Materials price target raised to $55 from $50 at DA Davidson
05/15/20 Needham
Applied Materials price target lowered to $70 from $73 at Needham
05/15/20 B. Riley FBR
B. Riley FBR upgrades Applied Materials to Buy on growth visibility
LRCX Lam Research
$252.00 /

-17.19 (-6.39%)

04/23/20 DA Davidson
Lam Research price target raised to $270 from $250 at DA Davidson
04/23/20 Wells Fargo
Lam Research price target raised to $270 from $210 at Wells Fargo
04/23/20 Susquehanna
Lam Research price target lowered to $330 from $368 at Susquehanna
04/23/20 Needham
Lam Research price target lowered to $325 from $340 at Needham
TSM TSMC
$49.52 /

-2.6 (-4.99%)

04/28/20
Fly Intel: Top five analyst initiations
04/28/20 Wedbush
Wedbush bullish on TSMC, initiates with an Outperform
04/27/20 Wedbush
TSMC initiated with an Outperform at Wedbush
04/17/20 Susquehanna
TSMC downgraded to Negative from Positive at Susquehanna
KLAC KLA Corp.
$168.66 /

-7.3 (-4.15%)

05/06/20 Wells Fargo
KLA Corp. price target raised to $160 from $140 at Wells Fargo
05/06/20 KeyBanc
KLA Corp. price target lowered to $182 from $204 at KeyBanc
05/06/20 Citi
KLA Corp. price target raised to $178 from $158 at Citi
04/08/20 Exane BNP Paribas
KLA Corp. reinstated with an Outperform at Exane BNP Paribas
FB Facebook
$207.15 /

+0.42 (+0.20%)

05/15/20 Loop Capital
Facebook price target raised to $265 from $215 at Loop Capital
05/04/20 Argus
Facebook price target raised to $240 from $220 at Argus
05/01/20 BMO Capital
Facebook price target raised to $220 from $190 at BMO Capital
04/30/20
Fly Intel: Top five analyst upgrades
ABT Abbott
$89.66 /

-2.055 (-2.24%)

04/20/20 Barclays
Abbott price target raised to $100 from $92 at Barclays
04/20/20 Barclays
Abbott price target raised to $100 from $92 at Barclays
04/17/20 Raymond James
Abbott price target raised to $102 from $92 at Raymond James
04/17/20 Credit Suisse
Abbott price target raised to $106 from $95 at Credit Suisse
SRNE Sorrento Therapeutics
$7.72 /

+5.095 (+194.10%)

10/07/19 JMP Securities
Sorrento Therapeutics initiated with an Outperform at JMP Securities
07/23/19 H.C. Wainwright
Sorrento Therapeutics price target lowered to $30 from $40 at H.C. Wainwright
ODP Office Depot
$2.18 /

+0.175 (+8.73%)

04/30/20 Sidoti
Office Depot initiated with a Buy at Sidoti
08/20/19 BofA
Office Depot price target lowered to $1.20 from $2 at BofA/Merrill
ACB Aurora Cannabis
$11.25 /

+4.64 (+70.20%)

05/15/20 MKM Partners
Aurora Cannabis price target raised to C$12 from C$1 at MKM Partners
05/15/20 Piper Sandler
Aurora Cannabis upgraded to Neutral from Underweight at Piper Sandler
05/13/20 Cantor Fitzgerald
Aurora Cannabis price target raised to C$22 from C$2.75 at Cantor Fitzgerald
04/08/20 Raymond James
Ontario AG order positive for Canadian cannabis stocks, says Raymond James
DDS Dillard's
$24.69 /

+1.75 (+7.63%)

05/15/20 JPMorgan
Dillard's price target lowered to $23 from $32 at JPMorgan
05/07/20 Deutsche Bank
Dillard's price target lowered to $18 from $36 at Deutsche Bank
04/30/20 Wedbush
Dillard's price target lowered to $25 from $63 at Wedbush
01/24/20 Odeon Capital
Dillard's initiated with a Sell at Odeon Capital
GOOS Canada Goose
$19.19 /

-1.49 (-7.21%)

05/15/20 BofA
Canada Goose downgraded to Underperform from Neutral at BofA
05/15/20 BofA
Canada Goose downgraded to Underperform from Neutral at BofA
04/28/20 BTIG
Canada Goose initiated with a Buy at BTIG
04/15/20 CIBC
Canada Goose price target lowered to C$35 from C$57 at CIBC
CODX Co-Diagnostics
$17.49 /

-4.7 (-21.18%)

03/09/20 H.C. Wainwright
Co-Diagnostics price target raised to $20 from $4 at H.C. Wainwright
03/03/20
Fly Intel: Top five analyst downgrades
03/03/20 Maxim
Co-Diagnostics downgraded to Hold from Buy at Maxim
03/03/20 Maxim
Co-Diagnostics downgraded to Hold from Buy at Maxim
QCOM Qualcomm
$75.37 /

-4.49 (-5.62%)

05/04/20
Fly Intel: Top five analyst initiations
05/04/20 KeyBanc
Apple cautious iPhone outlook likely a headwind for chip suppliers, says KeyBanc
05/04/20 Wells Fargo
Qualcomm initiated with an Underweight at Wells Fargo
05/04/20 Wells Fargo
Qualcomm initiated with an Underweight at Wells Fargo
AAPL Apple
$304.43 /

-5.13 (-1.66%)

05/12/20 Wedbush
Apple price target raised to $350 from $335 at Wedbush
05/07/20 Bernstein
Google payments to Apple big, predicated on advertising, says Bernstein
05/06/20 Morgan Stanley
Apple's App Store just had strongest month in 2.5 years, says Morgan Stanley
05/06/20 Daiwa
Apple price target raised to $320 from $297 at Daiwa
BA Boeing
$119.50 /

-2.95 (-2.41%)

05/05/20 Nord/LB
Boeing downgraded to Sell from Hold at Nord/LB
05/04/20 BofA
Embraer downgraded to Neutral from Buy at BofA
05/01/20 JPMorgan
Boeing price target raised to $158 from $130 at JPMorgan
04/30/20 Goldman Sachs
Goldman boosts Boeing price target to $209 on positive stabilization steps
CSCO Cisco
$44.01 /

+0.14 (+0.32%)

05/14/20 Needham
Cisco recovery to be a slow process, says Needham
05/14/20 JPMorgan
Cisco fiscal Q3 results better than feared, says JPMorgan
05/14/20 Morgan Stanley
Cisco too broadly exposed to macro to be more positive, says Morgan Stanley
05/14/20 Baird
Cisco price target raised to $48 from $46 at Baird
TSM TSMC
$49.52 /

-2.6 (-4.99%)

QCOM Qualcomm
$75.37 /

-4.49 (-5.62%)

ODP Office Depot
$2.18 /

+0.175 (+8.73%)

LRCX Lam Research
$252.00 /

-17.19 (-6.39%)

KLAC KLA Corp.
$168.66 /

-7.3 (-4.15%)

GOOS Canada Goose
$19.19 /

-1.49 (-7.21%)

FB Facebook
$207.15 /

+0.42 (+0.20%)

DDS Dillard's
$24.69 /

+1.75 (+7.63%)

CSCO Cisco
$44.01 /

+0.14 (+0.32%)

CODX Co-Diagnostics
$17.49 /

-4.7 (-21.18%)

BA Boeing
$119.50 /

-2.95 (-2.41%)

AMAT Applied Materials
$51.41 /

-3.1 (-5.69%)

ACB Aurora Cannabis
$11.25 /

+4.64 (+70.20%)

ABT Abbott
$89.66 /

-2.055 (-2.24%)

AAPL Apple
$304.43 /

-5.13 (-1.66%)

TSM TSMC
$49.52 /

-2.6 (-4.99%)

SRNE Sorrento Therapeutics
$7.72 /

+5.095 (+194.10%)

QCOM Qualcomm
$75.37 /

-4.49 (-5.62%)

LRCX Lam Research
$252.00 /

-17.19 (-6.39%)

GOOS Canada Goose
$19.19 /

-1.49 (-7.21%)

FB Facebook
$207.15 /

+0.42 (+0.20%)

CSCO Cisco
$44.01 /

+0.14 (+0.32%)

CODX Co-Diagnostics
$17.49 /

-4.7 (-21.18%)

BA Boeing
$119.50 /

-2.95 (-2.41%)

AMAT Applied Materials
$51.41 /

-3.1 (-5.69%)

ACB Aurora Cannabis
$11.25 /

+4.64 (+70.20%)

ABT Abbott
$89.66 /

-2.055 (-2.24%)

AAPL Apple
$304.43 /

-5.13 (-1.66%)

TSM TSMC
$49.52 /

-2.6 (-4.99%)

SRNE Sorrento Therapeutics
$7.72 /

+5.095 (+194.10%)

QCOM Qualcomm
$75.37 /

-4.49 (-5.62%)

ODP Office Depot
$2.18 /

+0.175 (+8.73%)

LRCX Lam Research
$252.00 /

-17.19 (-6.39%)

KLAC KLA Corp.
$168.66 /

-7.3 (-4.15%)

GOOS Canada Goose
$19.19 /

-1.49 (-7.21%)

FB Facebook
$207.15 /

+0.42 (+0.20%)

CSCO Cisco
$44.01 /

+0.14 (+0.32%)

CODX Co-Diagnostics
$17.49 /

-4.7 (-21.18%)

BA Boeing
$119.50 /

-2.95 (-2.41%)

AMAT Applied Materials
$51.41 /

-3.1 (-5.69%)

ACB Aurora Cannabis
$11.25 /

+4.64 (+70.20%)

ABT Abbott
$89.66 /

-2.055 (-2.24%)

AAPL Apple
$304.43 /

-5.13 (-1.66%)

TSM TSMC
$49.52 /

-2.6 (-4.99%)

SRNE Sorrento Therapeutics
$7.72 /

+5.095 (+194.10%)

QCOM Qualcomm
$75.37 /

-4.49 (-5.62%)

LRCX Lam Research
$252.00 /

-17.19 (-6.39%)

GOOS Canada Goose
$19.19 /

-1.49 (-7.21%)

FB Facebook
$207.15 /

+0.42 (+0.20%)

CSCO Cisco
$44.01 /

+0.14 (+0.32%)

CODX Co-Diagnostics
$17.49 /

-4.7 (-21.18%)

BA Boeing
$119.50 /

-2.95 (-2.41%)

AMAT Applied Materials
$51.41 /

-3.1 (-5.69%)

ACB Aurora Cannabis
$11.25 /

+4.64 (+70.20%)

ABT Abbott
$89.66 /

-2.055 (-2.24%)

AAPL Apple
$304.43 /

-5.13 (-1.66%)

AAPL Apple
$304.43 /

-5.13 (-1.66%)

On The Fly
Fly Intel: After-Hours Movers » 19:11
05/14/20
05/14
19:11
05/14/20
19:11
YTEN

Yield10 Bioscience

$4.92 /

-0.02 (-0.40%)

, OPRT

Oportun Financial

$6.00 /

-0.25 (-4.00%)

, DENN

Denny's

$8.77 /

-0.035 (-0.40%)

, ACB

Aurora Cannabis

$6.61 /

+0.79 (+13.57%)

, AEYE

AudioEye

$8.88 /

+0.71 (+8.69%)

, NEWR

New Relic

$58.22 /

+1.62 (+2.86%)

, DDS

Dillard's

$22.94 /

-1.15 (-4.77%)

, AMAT

Applied Materials

$54.51 /

+2.98 (+5.78%)

, GLOB

Globant

$111.38 /

+3.1 (+2.86%)

, OCUL

Ocular Therapeutix

$6.01 /

-0.3 (-4.75%)

, REGN

Regeneron

$569.80 /

-7.58 (-1.31%)

, CODX

Co-Diagnostics

$22.19 /

-1.2 (-5.13%)

, FTCH

Farfetch

$15.94 /

+0.35 (+2.25%)

, CVET

Covetrus

$11.25 /

+0.3 (+2.74%)

, ETON

Eton Pharmaceuticals

$5.20 /

+0.03 (+0.58%)

, AUPH

Aurinia Pharmaceuticals

$17.39 /

-0.19 (-1.08%)

, VVI

Viad

$16.65 /

+0.71 (+4.45%)

, TGTX

TG Therapeutics

$19.90 /

-0.72 (-3.49%)

Check out this evening's…

Open Full Text

ShowHide Related Items >><<
YTEN Yield10 Bioscience
$4.92 /

-0.02 (-0.40%)

VVI Viad
$16.65 /

+0.71 (+4.45%)

TGTX TG Therapeutics
$19.90 /

-0.72 (-3.49%)

REGN Regeneron
$569.80 /

-7.58 (-1.31%)

OPRT Oportun Financial
$6.00 /

-0.25 (-4.00%)

OCUL Ocular Therapeutix
$6.01 /

-0.3 (-4.75%)

NEWR New Relic
$58.22 /

+1.62 (+2.86%)

GLOB Globant
$111.38 /

+3.1 (+2.86%)

FTCH Farfetch
$15.94 /

+0.35 (+2.25%)

ETON Eton Pharmaceuticals
$5.20 /

+0.03 (+0.58%)

DENN Denny's
$8.77 /

-0.035 (-0.40%)

DDS Dillard's
$22.94 /

-1.15 (-4.77%)

CVET Covetrus
$11.25 /

+0.3 (+2.74%)

CODX Co-Diagnostics
$22.19 /

-1.2 (-5.13%)

AUPH Aurinia Pharmaceuticals
$17.39 /

-0.19 (-1.08%)

AMAT Applied Materials
$54.51 /

+2.98 (+5.78%)

AEYE AudioEye
$8.88 /

+0.71 (+8.69%)

ACB Aurora Cannabis
$6.61 /

+0.79 (+13.57%)

YTEN Yield10 Bioscience
$4.92 /

-0.02 (-0.40%)

12/11/19 Ladenburg
Yield10 Bioscience price target lowered to $1 from $7 at Ladenburg
11/18/19 National Securities
Yield10 Bioscience downgraded to Neutral from Buy at National Securities
07/22/19 Aegis
Yield10 Bioscience initiated with a Buy at Aegis
OPRT Oportun Financial
$6.00 /

-0.25 (-4.00%)

04/07/20 BTIG
Oportun Financial price target lowered to $19 from $27 at BTIG
01/17/20 JPMorgan
Oportun Financial downgraded to Neutral on valuation at JPMorgan
01/17/20 JPMorgan
Oportun Financial downgraded to Neutral from Overweight at JPMorgan
12/23/19 BTIG
Oportun Financial price target raised to $27 from $22 at BTIG
DENN Denny's
$8.77 /

-0.035 (-0.40%)

04/08/20 Oppenheimer
Denny's price target lowered to $13 from $27 at Oppenheimer
04/01/20 SunTrust
El Pollo Loco upgraded to Buy from Hold at SunTrust
04/01/20 SunTrust
Denny's upgraded to Buy from Hold at SunTrust
03/20/20 Stephens
Denny's price target lowered to $12 from $19 at Stephens
ACB Aurora Cannabis
$6.61 /

+0.79 (+13.57%)

05/13/20 Cantor Fitzgerald
Aurora Cannabis price target raised to C$22 from C$2.75 at Cantor Fitzgerald
04/08/20 Raymond James
Ontario AG order positive for Canadian cannabis stocks, says Raymond James
02/27/20 Bryan Garnier
Aurora Cannabis downgraded to Sell from Neutral at Bryan Garnier
02/25/20 Needham
Aurora Cannabis initiated with a Hold at Needham
AEYE AudioEye
$8.88 /

+0.71 (+8.69%)

10/24/19 National Securities
AudioEye resumed with a Buy at National Securities
05/31/19 B. Riley FBR
AudioEye selloff brings 'compelling' entry point, syays B. Riley FBR
NEWR New Relic
$58.22 /

+1.62 (+2.86%)

04/27/20 Needham
New Relic price target lowered to $74 from $108 at Needham
04/14/20 Morgan Stanley
New Relic downgraded to Equal Weight amid weaker backdrop at Morgan Stanley
04/14/20 Morgan Stanley
New Relic downgraded to Equal Weight from Overweight at Morgan Stanley
04/06/20 Rosenblatt
New Relic initiated with a Neutral at Rosenblatt
DDS Dillard's
$22.94 /

-1.15 (-4.77%)

05/07/20 Deutsche Bank
Dillard's price target lowered to $18 from $36 at Deutsche Bank
04/30/20 Wedbush
Dillard's price target lowered to $25 from $63 at Wedbush
01/24/20 Odeon Capital
Dillard's initiated with a Sell at Odeon Capital
11/11/19 Deutsche Bank
L Brands downgraded to Hold from Buy at Deutsche Bank
AMAT Applied Materials
$54.51 /

+2.98 (+5.78%)

05/12/20 Susquehanna
Applied Materials fundamentals strong ahead of results, says Susquehanna
05/11/20 Cowen
Applied Materials sales trajectory has positive slope, says Cowen
05/08/20 Wells Fargo
Applied Materials price target raised to $60 from $50 at Wells Fargo
04/14/20 Deutsche Bank
Applied Materials share underperformance unwarranted, says Deutsche Bank
GLOB Globant
$111.38 /

+3.1 (+2.86%)

04/29/20 Goldman Sachs
Globant price target lowered to $130 from $165 at Goldman Sachs
04/16/20 Wedbush
Globant price target lowered to $120 from $150 at Wedbush
03/10/20 KeyBanc
Globant downgraded to Sector Weight from Overweight at KeyBanc
02/21/20 Cantor Fitzgerald
Globant price target raised to $120 from $97 at Cantor Fitzgerald
OCUL Ocular Therapeutix
$6.01 /

-0.3 (-4.75%)

05/08/20 Piper Sandler
Ocular Therapeutix long-term opportunity intact, says Piper Sandler
04/29/20 H.C. Wainwright
Ocular Therapeutix price target raised to $10 from $8 at H.C. Wainwright
04/28/20 Piper Sandler
Ocular Therapeutix data warrant discussions with FDA, says Piper Sandler
03/04/20 Piper Sandler
Ocular Therapeutix price target raised to $11 from $7 at Piper Sandler
REGN Regeneron
$569.80 /

-7.58 (-1.31%)

05/14/20 Piper Sandler
Piper 'incrementally positive' on Regeneron shares after fireside chat
05/06/20 Canaccord
Regeneron price target raised to $630 from $575 at Canaccord
05/06/20 BMO Capital
Regeneron price target raised to $525 from $466 at BMO Capital
05/06/20 SVB Leerink
Regeneron price target raised to $622 from $604 at SVB Leerink
CODX Co-Diagnostics
$22.19 /

-1.2 (-5.13%)

03/09/20 H.C. Wainwright
Co-Diagnostics price target raised to $20 from $4 at H.C. Wainwright
03/03/20
Fly Intel: Top five analyst downgrades
03/03/20 Maxim
Co-Diagnostics downgraded to Hold from Buy at Maxim
03/03/20 Maxim
Co-Diagnostics downgraded to Hold from Buy at Maxim
FTCH Farfetch
$15.94 /

+0.35 (+2.25%)

05/14/20 KeyBanc
Farfetch, Nordstrom, Revolve could be impacted by Amazon offering, says KeyBanc
03/30/20 Wells Fargo
Farfetch downgraded to Underweight from Equal Weight at Wells Fargo
02/28/20 KeyBanc
Farfetch price target lowered to $17 from $20 at KeyBanc
11/15/19 Credit Suisse
Farfetch price target lowered to $17 from $22 at Credit Suisse
CVET Covetrus
$11.25 /

+0.3 (+2.74%)

09/09/19 Goldman Sachs
Covetrus initiated with a Sell at Goldman Sachs
08/14/19 Stifel
Covetrus price target lowered to $18 from $30 at Stifel
08/14/19 William Blair
Covetrus risk/reward 'intriguing' after selloff, says William Blair
05/23/19 Guggenheim
Covetrus initiated with a Neutral at Guggenheim
ETON Eton Pharmaceuticals
$5.20 /

+0.03 (+0.58%)

03/30/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $26 from $23 at H.C. Wainwright
01/28/20 H.C. Wainwright
Eton Pharmaceuticals price target raised to $23 from $21 at H.C. Wainwright
10/23/19 H.C. Wainwright
Eton Pharmaceuticals price target raised to $21 from $18 at H.C. Wainwright
09/20/19
Fly Intel: Top five analyst initiations
AUPH Aurinia Pharmaceuticals
$17.39 /

-0.19 (-1.08%)

05/05/20 Cowen
Aurinia Pharmaceuticals initiated with an Outperform at Cowen
03/16/20 H.C. Wainwright
Aurinia's voclosporin could get FDA approval in 1Q21, says H.C. Wainwright
01/10/20 Jefferies
Aurinia Pharmaceuticals initiated with a Buy at Jefferies
12/16/19 H.C. Wainwright
Aurinia Pharmaceuticals price target raised to $32 from $25 at H.C. Wainwright
VVI Viad
$16.65 /

+0.71 (+4.45%)

TGTX TG Therapeutics
$19.90 /

-0.72 (-3.49%)

05/06/20 Cantor Fitzgerald
TG Therapeutics price target raised to $35 from $19 at Cantor Fitzgerald
05/05/20 B. Riley FBR
TG Therapeutics price target raised to $29 from $25 at B. Riley FBR
05/05/20 H.C. Wainwright
TG Therapeutics price target raised to $32 from $24 at H.C. Wainwright
01/17/20 B. Riley FBR
TG Therapeutics price target raised to $25 from $17 at B. Riley FBR
YTEN Yield10 Bioscience
$4.92 /

-0.02 (-0.40%)

VVI Viad
$16.65 /

+0.71 (+4.45%)

TGTX TG Therapeutics
$19.90 /

-0.72 (-3.49%)

REGN Regeneron
$569.80 /

-7.58 (-1.31%)

OPRT Oportun Financial
$6.00 /

-0.25 (-4.00%)

OCUL Ocular Therapeutix
$6.01 /

-0.3 (-4.75%)

NEWR New Relic
$58.22 /

+1.62 (+2.86%)

GLOB Globant
$111.38 /

+3.1 (+2.86%)

FTCH Farfetch
$15.94 /

+0.35 (+2.25%)

ETON Eton Pharmaceuticals
$5.20 /

+0.03 (+0.58%)

DENN Denny's
$8.77 /

-0.035 (-0.40%)

DDS Dillard's
$22.94 /

-1.15 (-4.77%)

CVET Covetrus
$11.25 /

+0.3 (+2.74%)

CODX Co-Diagnostics
$22.19 /

-1.2 (-5.13%)

AUPH Aurinia Pharmaceuticals
$17.39 /

-0.19 (-1.08%)

AMAT Applied Materials
$54.51 /

+2.98 (+5.78%)

AEYE AudioEye
$8.88 /

+0.71 (+8.69%)

ACB Aurora Cannabis
$6.61 /

+0.79 (+13.57%)

  • 15
    May
REGN Regeneron
$569.80 /

-7.58 (-1.31%)

CODX Co-Diagnostics
$22.19 /

-1.2 (-5.13%)

AUPH Aurinia Pharmaceuticals
$17.39 /

-0.19 (-1.08%)

AMAT Applied Materials
$54.51 /

+2.98 (+5.78%)

ACB Aurora Cannabis
$6.61 /

+0.79 (+13.57%)

YTEN Yield10 Bioscience
$4.92 /

-0.02 (-0.40%)

TGTX TG Therapeutics
$19.90 /

-0.72 (-3.49%)

REGN Regeneron
$569.80 /

-7.58 (-1.31%)

FTCH Farfetch
$15.94 /

+0.35 (+2.25%)

DENN Denny's
$8.77 /

-0.035 (-0.40%)

CVET Covetrus
$11.25 /

+0.3 (+2.74%)

CODX Co-Diagnostics
$22.19 /

-1.2 (-5.13%)

AUPH Aurinia Pharmaceuticals
$17.39 /

-0.19 (-1.08%)

AMAT Applied Materials
$54.51 /

+2.98 (+5.78%)

ACB Aurora Cannabis
$6.61 /

+0.79 (+13.57%)

TGTX TG Therapeutics
$19.90 /

-0.72 (-3.49%)

REGN Regeneron
$569.80 /

-7.58 (-1.31%)

FTCH Farfetch
$15.94 /

+0.35 (+2.25%)

DENN Denny's
$8.77 /

-0.035 (-0.40%)

CODX Co-Diagnostics
$22.19 /

-1.2 (-5.13%)

AUPH Aurinia Pharmaceuticals
$17.39 /

-0.19 (-1.08%)

AMAT Applied Materials
$54.51 /

+2.98 (+5.78%)

ACB Aurora Cannabis
$6.61 /

+0.79 (+13.57%)

Hot Stocks
Co-Diagnostics says COVID-19 test demonstrated 'excellent performance' » 18:05
05/14/20
05/14
18:05
05/14/20
18:05
CODX

Co-Diagnostics

$22.19 /

-1.2 (-5.13%)

The company releases the…

The company releases the prepared remarks for its Q1 earnings call, stating: "At the present time, timelines for effective coronavirus vaccines and therapeutics remain uncertain. What is widely known is that the need for testing on a mass scale continues to grow, as the U.S. and countries around the world strive to create COVID-safe schools, COVID-safe workspaces, and COVID-safe communities. In the United States for example there are more than 76 million students that need to be in school this fall along with 157 million workers who need to be at work. During the pandemic, Co-Diagnostics' ability to utilize its patented CoPrimer technology in highly accurate tests has significantly changed the trajectory of our Company. Co-Diagnostics was the first U.S. based company to receive a CE marking for its COVID-19 test, giving us an early entry into the European market as well as other areas of the world that accept CE marking as valid regulatory approval. In addition, being granted the FDA's emergency use authorization on April 3rd has been critical in fast-tracking the Company's COVID-19 diagnostic solution. We believe that test performance, combined with competitive pricing and high throughput attributes, makes for a compelling value proposition. Our COVID-19 test has been the subject of several independent studies validating its specificity and sensitivity, which have demonstrated its excellent performance characteristics."

ShowHide Related Items >><<
CODX Co-Diagnostics
$22.19 /

-1.2 (-5.13%)

CODX Co-Diagnostics
$22.19 /

-1.2 (-5.13%)

03/09/20 H.C. Wainwright
Co-Diagnostics price target raised to $20 from $4 at H.C. Wainwright
03/03/20
Fly Intel: Top five analyst downgrades
03/03/20 Maxim
Co-Diagnostics downgraded to Hold from Buy at Maxim
03/03/20 Maxim
Co-Diagnostics downgraded to Hold from Buy at Maxim
CODX Co-Diagnostics
$22.19 /

-1.2 (-5.13%)

CODX Co-Diagnostics
$22.19 /

-1.2 (-5.13%)

CODX Co-Diagnostics
$22.19 /

-1.2 (-5.13%)

CODX Co-Diagnostics
$22.19 /

-1.2 (-5.13%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.